SFM
ONCE

Sphera Funds Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Sphera Funds Management’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-100,000
Closed -$5.14M – 160
2017
Q4 		$5.14M Buy
+100,000
New +$7.18M 0.6% 38
2015
Q4 		– Sell
-70,000
Closed -$2.92M – 144
2015
Q3 		$2.92M Buy
+70,000
New +$3.65M 0.37% 63

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Sphera Funds Management's ONCE Position: Q1 2018 in Review

Sphera Funds Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2018, closing a stake of 100,000 shares — an estimated $5.14M sold.

Sphera Funds Management first reported a position in ONCE in Q3 2015 and held it in 2 quarters. The position peaked at $5.14M in Q4 2017. 162 funds tracked by Wall St. Rank hold ONCE as of Q1 2018.

  • Sphera Funds Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Sphera Funds Management sold 100,000 Spark Therapeutics, Inc. Common Stock shares in Q1 2018, an estimated $5.14M.
  • Sphera Funds Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2015 and held it in 2 quarters.
  • Sphera Funds Management's Spark Therapeutics, Inc. Common Stock position peaked at $5.14M in Q4 2017.
  • 162 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2018.

Based on Sphera Funds Management's 13F filing for Q1 2018, filed 10 May 2018.